Anti-Zinc finger protein 711 Chemische Eigenschaften,Einsatz,Produktion Methoden
Verwenden
All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project
(www.proteinatlas.org)and as a result, are supported by the most extensive characterization in the industry.
The Human Protein Atlas project can be subdivided into three efforts: Human Tissue Atlas, Cancer Atlas, and Human Cell Atlas. The antibodies that have been generated in support of the Tissue and Cancer Atlas projects have been tested by immunohistochemistry against hundreds of normal and disease tissues and through the recent efforts of the Human Cell Atlas project, many have been characterized by immunofluorescence to map the human proteome not only at the tissue level but now at the subcellular level. These images and the collection of this vast data set can be viewed on the Human Protein Atlas (HPA) site by clicking on the Image Gallery link. To view these
protocols and other useful information about Prestige Antibodies and the HPA, visit .
Allgemeine Beschreibung
ZNF711 (zinc finger protein 711) gene is mapped to human chromosome Xq21.1 and encodes a zinc finger transcription factor. This gene is highly expressed in fetal brain, less expressed in heart, kidney, and lung and least expressed in liver. The protein contains an amino-terminal potential domain that may be involved in transcriptional activation, and 12 Zn-C
2H
2 domains significantly involved in sequence-specific DNA binding region.
Biochem/physiol Actions
Mutation in ZNF711 (zinc finger protein 711) might cause non-syndromic intellectual disability, which is characterized by reduced cognitive ability and mental retardation.
Anti-Zinc finger protein 711 Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
